EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CD93 in Health and Disease: Bridging Physiological Functions and Clinical Applications

Menghan Cai iD, Xiaoxi Zhou, Songna Wang, Xuan Huang iD, Wei Chen, Yiling Chen, Litao Huang, Yan Yan, Yizhun Zhu iD, Li Ye iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178617 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Menghan Cai und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Laboratory of Drug Discovery from Natural Resources and Industrialization, Macau University of Science and Technology, Macau S…. Hauptthemen laut MEDLINE: Membrane Glycoproteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Macao Science and Technology Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD93 is a highly glycosylated transmembrane glycoprotein with key functional domains, including a C-type lectin-like domain (CTLD) and epidermal growth factor (EGF)-like domains. Primarily expressed in endothelial cells (ECs), CD93 regulates critical physiological processes such as angiogenesis, cell adhesion, migration, and apoptotic cell clearance through interactions with ligands like multimerin-2 (MMRN2) and insulin-like growth factor-binding protein 7 (IGFBP7). Aberrant CD93 expression has been observed in various pathological conditions, including inflammation, cardiovascular diseases, autoimmune disorders, and cancer. Notably, CD93 is overexpressed in tumor-associated blood vessels, which is associated with poor prognosis and advanced disease stages. Targeting the CD93 signaling pathway has the potential to improve tumor vascular function and enhance the efficacy of immunotherapy, making it a promising therapeutic target. This review summarizes the current understanding of CD93’s structure, function, and disease mechanisms, providing a framework for further research and clinical translation in related fields.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane GlycoproteinsHumansAnimalsNeoplasmsSignal TransductionCardiovascular DiseasesAutoimmune DiseasesInflammationEndothelial CellsReceptors, Complement

Stichwörter der Autor:innen

CD93cancerimmune checkpoint inhibitorsimmunotherapytumor angiogenesis

Substanzen

complement 1q receptorMembrane GlycoproteinsReceptors, Complement

Autor:innen und Institutionen

  • School of Pharmacy and Laboratory of Drug Discovery from Natural Resources and Industrialization, Macau University of Science and Technology, Macau SAR 999078, China.
  • Department of Biological Medicines, Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201103, China.

ORCID-Profile: Menghan Cai, Xuan Huang, Yizhun Zhu, Li Ye

Förderung

  • Macao Science and Technology Development Fund

Zitieren

APA

Cai, M., Zhou, X., Wang, S., Huang, X., Chen, W., Chen, Y., Huang, L., Yan, Y., Zhu, Y., & Ye, L. (2025). CD93 in Health and Disease: Bridging Physiological Functions and Clinical Applications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178617

Vancouver

Cai M, Zhou X, Wang S, Huang X, Chen W, Chen Y, et al. CD93 in Health and Disease: Bridging Physiological Functions and Clinical Applications. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178617

BibTeX
@article{Cai2025,
  author = {Cai, Menghan and Zhou, Xiaoxi and Wang, Songna and Huang, Xuan and Chen, Wei and Chen, Yiling and Huang, Litao and Yan, Yan and Zhu, Yizhun and Ye, Li},
  title = {CD93 in Health and Disease: Bridging Physiological Functions and Clinical Applications},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178617}
}
Kostenlos starten →